264 related articles for article (PubMed ID: 31549334)
1. Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis.
García-Collinot G; Madrigal-Santillán EO; Martínez-Bencomo MA; Carranza-Muleiro RA; Jara LJ; Vera-Lastra O; Montes-Cortes DH; Medina G; Cruz-Domínguez MP
Dig Dis Sci; 2020 Apr; 65(4):1134-1143. PubMed ID: 31549334
[TBL] [Abstract][Full Text] [Related]
2. Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study.
Bustos Fernández LM; Man F; Lasa JS
Dig Dis; 2023; 41(5):798-809. PubMed ID: 36630947
[TBL] [Abstract][Full Text] [Related]
3. Small intestinal bacterial overgrowth in systemic sclerosis.
Marie I; Ducrotté P; Denis P; Menard JF; Levesque H
Rheumatology (Oxford); 2009 Oct; 48(10):1314-9. PubMed ID: 19696066
[TBL] [Abstract][Full Text] [Related]
4. Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review.
Pittman N; Rawn SM; Wang M; Masetto A; Beattie KA; Larché M
Rheumatology (Oxford); 2018 Oct; 57(10):1802-1811. PubMed ID: 29982822
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms.
Tauber M; Avouac J; Benahmed A; Barbot L; Coustet B; Kahan A; Allanore Y
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-82-7. PubMed ID: 25372792
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO)--a pilot study.
Khalighi AR; Khalighi MR; Behdani R; Jamali J; Khosravi A; Kouhestani Sh; Radmanesh H; Esmaeelzadeh S; Khalighi N
Indian J Med Res; 2014 Nov; 140(5):604-8. PubMed ID: 25579140
[TBL] [Abstract][Full Text] [Related]
7. Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.
Leventogiannis K; Gkolfakis P; Spithakis G; Tsatali A; Pistiki A; Sioulas A; Giamarellos-Bourboulis EJ; Triantafyllou K
Probiotics Antimicrob Proteins; 2019 Jun; 11(2):627-634. PubMed ID: 29508268
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients.
Sawadpanich K; Soison P; Chunlertrith K; Mairiang P; Sukeepaisarnjaroen W; Sangchan A; Suttichaimongkol T; Foocharoen C
Int J Rheum Dis; 2019 Apr; 22(4):695-699. PubMed ID: 30729669
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysis.
Feng X; Li XQ; Jiang Z
Clin Rheumatol; 2021 Aug; 40(8):3039-3051. PubMed ID: 33426631
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
[TBL] [Abstract][Full Text] [Related]
11. Small intestinal bacterial overgrowth in systemic sclerosis: a review of the literature.
Polkowska-Pruszyńska B; Gerkowicz A; Szczepanik-Kułak P; Krasowska D
Arch Dermatol Res; 2019 Jan; 311(1):1-8. PubMed ID: 30382339
[TBL] [Abstract][Full Text] [Related]
12. Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth.
Roland BC; Ciarleglio MM; Clarke JO; Semler JR; Tomakin E; Mullin GE; Pasricha PJ
J Clin Gastroenterol; 2015 Aug; 49(7):571-6. PubMed ID: 25319735
[TBL] [Abstract][Full Text] [Related]
13. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication.
Parodi A; Sessarego M; Greco A; Bazzica M; Filaci G; Setti M; Savarino E; Indiveri F; Savarino V; Ghio M
Am J Gastroenterol; 2008 May; 103(5):1257-62. PubMed ID: 18422815
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of antibiotherapy for treating flatus incontinence associated with small intestinal bacterial overgrowth: A pilot randomized trial.
Melchior C; Gourcerol G; Bridoux V; Ducrotté P; Quinton JF; Leroi AM
PLoS One; 2017; 12(8):e0180835. PubMed ID: 28763464
[TBL] [Abstract][Full Text] [Related]
15. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers.
Kabbani TA; Pallav K; Dowd SE; Villafuerte-Galvez J; Vanga RR; Castillo NE; Hansen J; Dennis M; Leffler DA; Kelly CP
Gut Microbes; 2017 Jan; 8(1):17-32. PubMed ID: 27973989
[TBL] [Abstract][Full Text] [Related]
16. Fecal calprotectin in systemic sclerosis and review of the literature.
Marie I; Leroi AM; Menard JF; Levesque H; Quillard M; Ducrotte P
Autoimmun Rev; 2015 Jun; 14(6):547-54. PubMed ID: 25661980
[TBL] [Abstract][Full Text] [Related]
17. [Comparative clinical efficacy of a probiotic vs. an antibiotic in the treatment of patients with intestinal bacterial overgrowth and chronic abdominal functional distension: a pilot study].
Soifer LO; Peralta D; Dima G; Besasso H
Acta Gastroenterol Latinoam; 2010 Dec; 40(4):323-7. PubMed ID: 21381407
[TBL] [Abstract][Full Text] [Related]
18. Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management.
Rao SSC; Bhagatwala J
Clin Transl Gastroenterol; 2019 Oct; 10(10):e00078. PubMed ID: 31584459
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of trimethoprim-sulfamethoxazole and metronidazole in the treatment of small intestinal bacterial overgrowth in children living in a slum.
Tahan S; Melli LC; Mello CS; Rodrigues MS; Bezerra Filho H; de Morais MB
J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):316-8. PubMed ID: 23974062
[TBL] [Abstract][Full Text] [Related]
20. A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.
Zhao J; Zheng X; Chu H; Zhao J; Cong Y; Fried M; Fox M; Dai N
Neurogastroenterol Motil; 2014 Jun; 26(6):794-802. PubMed ID: 24641100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
